Homebiotech

biotech

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

FDA approves generalised myasthenia gravis drug

Jim Cornall - December 17, 2025

biotech

Breast cancer vaccine endpoints met with 74% immune response

Jim Cornall - December 17, 2025

biotech

Lilly to build $6bn Alabama facility

Jim Cornall - December 16, 2025

biotech

PsiThera unveiled with $47.5m funding to advance oral medicines

Jim Cornall - December 16, 2025

biotech

Rapid diagnostic breakthrough against Klebsiella

Jim Cornall - December 16, 2025

biotech

Pan Cancer T raises €10m for first-in-human trial of novel TCR-T cell therapy for triple-negative breast cancer

Jim Cornall - December 15, 2025

biotech

Vivacta Bio shows promising results for in vivo CAR-T therapy in non-Hodgkin’s lymphoma

Jim Cornall - December 15, 2025

biotech

OTR Therapeutics raises $100m for global transformative therapies

Jim Cornall - December 15, 2025

1...333435...78 Page 34 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026 0

Avaí Bio, Inc., an emerging biotechnology company developing cell-based therapies for diabetes, age-related disorders, and anti-aging, has announced - together with its joint venture...

Positive topline results from phase 2 recurrent ovarian cancer trial

biotech Jim Cornall - May 26, 2026 0

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0